Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Sasamura

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 26, 2002
[Prevention of hypertensive renal damage by prepubertal treatment with ARB]Hiroyuki Sasamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 17, 2007
[Use of angiotensin receptor blockers (ARBs) in the metabolic syndrome]Hiroyuki Sasamura, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 14, 2011
[Hypertension and arteriosclerosis]Hiroyuki Sasamura, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2011
[Angiotensin receptor vaccines]Hiroyuki Sasamura, Tatsuhiko Azegami, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 28, 2012
[Current status of vaccination therapy for hypertension]Hiroyuki Sasamura, Tatsuhiko Azegami, Hiroshi Itoh
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 14, 2011
Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathyTatsuhiko Azegami, Hiroyuki Sasamura, Kaori Hayashi, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2001
Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosisHideaki Nakaya, Hiroyuki Sasamura, Matsuhiko Hayashi, et al.
Journal of Atherosclerosis and Thrombosis|May 12, 2012
Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartanKaori Hayashi, Hiroyuki Sasamura, Tatsuhiko Azegami, et al.
Radiation Medicine|February 21, 2006
Hypertensive encephalopathy of brain stem with minimal supratentorial involvement: a rare manifestation of hypertensive encephalopathyHirokazu Fujiwara, Suketaka Momoshima, Sachio Kuribayashi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 13, 2006
Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and JapanYusuke Sakamaki, Hiroyuki Sasamura, Shunya Ikeda, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 26, 2002
[Prevention of hypertensive renal damage by prepubertal treatment with ARB]Hiroyuki Sasamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 17, 2007
[Use of angiotensin receptor blockers (ARBs) in the metabolic syndrome]Hiroyuki Sasamura, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 14, 2011
[Hypertension and arteriosclerosis]Hiroyuki Sasamura, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2011
[Angiotensin receptor vaccines]Hiroyuki Sasamura, Tatsuhiko Azegami, Hiroshi Itoh
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 28, 2012
[Current status of vaccination therapy for hypertension]Hiroyuki Sasamura, Tatsuhiko Azegami, Hiroshi Itoh
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 14, 2011
Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathyTatsuhiko Azegami, Hiroyuki Sasamura, Kaori Hayashi, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2001
Temporary treatment of prepubescent rats with angiotensin inhibitors suppresses the development of hypertensive nephrosclerosisHideaki Nakaya, Hiroyuki Sasamura, Matsuhiko Hayashi, et al.
Journal of Atherosclerosis and Thrombosis|May 12, 2012
Regression of atherosclerosis in apolipoprotein E-deficient mice is feasible using high-dose angiotensin receptor blocker, candesartanKaori Hayashi, Hiroyuki Sasamura, Tatsuhiko Azegami, et al.
Radiation Medicine|February 21, 2006
Hypertensive encephalopathy of brain stem with minimal supratentorial involvement: a rare manifestation of hypertensive encephalopathyHirokazu Fujiwara, Suketaka Momoshima, Sachio Kuribayashi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 13, 2006
Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and JapanYusuke Sakamaki, Hiroyuki Sasamura, Shunya Ikeda, et al.
Pageof 4